11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported

THURSDAY, Jan. 7, 2021 -- As of Dec. 23, 2020, researchers determined there were 21 cases of anaphylaxis (11.1 per million doses administered) after receipt of the first dose of the Pfizer-BioNTech COVID-19 vaccine in the United States, according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news